SEPTInvestingStart Free

AGEN 10-Q: SEC filing

Agenus Inc.

Filed with the SEC on · accession 0001193125-26-449984

AGEN filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.

Summary of the filing

Agenus Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing various transactions including a purchase agreement with Zydus, warrant issuances, and a promissory note.

For details, click here →How to read a 10-Q →

Key details

Counterparty to purchase agreementZydus Pharmaceuticals Inc.
Parent of zydus pharmaceuticalsZydus Lifesciences Ltd.
Subsidiary or affiliateMiNK Therapeutics, Inc.
Subsidiary or affiliateSaponiQx Inc.
Counterparty to purchase agreementLigand Pharmaceuticals Incorporated
Sales agent under at-market issuance sales agreementB. Riley FBR, Inc.

✦ Ask GOAX AI about this filing — what it means for AGEN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AGEN?

Click here

Frequently asked questions

What did AGEN file with the SEC on Nov 5, 2026?

AGEN filed a 10-Q (SEC filing). Agenus Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing various transactions including a purchase agreement with Zydus, warrant issuances, and a promissory note.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other AGEN SEC filings

Get alerts when AGEN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
AGEN overviewAGEN analysisAGEN newsLatest SEC filings